APA (7th ed.) Citation

W, X., J, F., Z, W., X, L., J, D., & C, L. (2026). Pleiotropic mechanisms of cancer-associated fibroblast-mediated resistance in hepatocellular carcinoma: Emerging therapeutic vulnerabilities and targeting strategies. Cancer gene therapy, 33(3), 338. https://doi.org/10.1038/s41417-026-01007-w

Chicago Style (17th ed.) Citation

W, Xie, Fang J, Wang Z, Li X, Du J, and Ling C. "Pleiotropic Mechanisms of Cancer-associated Fibroblast-mediated Resistance in Hepatocellular Carcinoma: Emerging Therapeutic Vulnerabilities and Targeting Strategies." Cancer Gene Therapy 33, no. 3 (2026): 338. https://doi.org/10.1038/s41417-026-01007-w.

MLA (9th ed.) Citation

W, Xie, et al. "Pleiotropic Mechanisms of Cancer-associated Fibroblast-mediated Resistance in Hepatocellular Carcinoma: Emerging Therapeutic Vulnerabilities and Targeting Strategies." Cancer Gene Therapy, vol. 33, no. 3, 2026, p. 338, https://doi.org/10.1038/s41417-026-01007-w.